Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot. Catheter directed thrombolysis of deep vein thrombosis.
Feature | Deep Vein Thrombosis (DVT) | Sanjay Pandya, M.D.

There are few downsides to using tibial venous access to treat deep vein thrombosis (DVT) with catheter-directed ...

Home February 16, 2018
Home
Technology | Thrombectomy Devices

The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo Retriever as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset, increasing the treatment window by 18 hours. The expanded indication of Stryker's clot-removal device is in line with the recently updated treatment guidelines from the American Heart Association (AHA) and American Stroke Association (ASA), and has the potential to reduce disability and improve quality of life for tens of thousands of additional stroke patients each year.

Home February 15, 2018
Home
News | Hemodynamic Support Devices

Abiomed Inc. announced that it received an expanded U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps to provide treatment for heart failure associated with cardiomyopathy leading to cardiogenic shock. This approval expands the previous FDA indication for acute myocardial infarction (AMI) cardiogenic shock and post-cardiotomy cardiogenic shock (PCCS), received in April 2016.

Home February 15, 2018
Home
News | Advanced Visualization

February 15, 2018 — The National Institutes of Health (NIH) awarded a $2.2 million research grant to healthcare ...

Home February 15, 2018
Home
Edwards Lifesciences Centera self expanding transcatheter (TAVR) valve has been approved with CE mark for use in Europe.
Feature | Heart Valve Technology

February 15, 2018 — Edwards Lifesciences Corp. has received European CE mark clearance for its self-expanding Centera ...

Home February 15, 2018
Home
Abiomed Impella percutaneous ventricular assist device (pVAD) heart pump gains FDA PMA for high risk PCI.
Feature | Hemodynamic Support Devices

February 14, 2018 — Abiomed Inc. announced it received an expanded U.S. Food and Drug Administration (FDA) pre-market ...

Home February 14, 2018
Home
Technology | Clinical Decision Support

February 14, 2018 — The U.S. Food and Drug Administration (FDA) announced marketing clearance for Viz.AI’s Contact ...

Home February 14, 2018
Home
The Boston Scientific Essentio MRI-safe pacemaker.
Feature | Pacemakers | Dave Fornell

There have been several advancements in pacemaker technologies over the past few years. This is an overview of some of ...

Home February 13, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet therapy (DAPT) in patients at high risk of bleeding after implantation with a Xience everolimus-eluting coronary stent. The first patient was enrolled into the study by Prof. Emanuele Barbato, M.D., Ph.D., a cardiologist at OLV-Hospital Aalst in Belgium.

Home February 13, 2018
Home
Women often present with different symptoms for cardiovascular disease then men. There are sex differences between men and women with heart disease.
Feature | Womens Cardiovascular Health | Jeff Zagoudis

Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD). This ...

Home February 12, 2018
Home
News

February 12, 2018 — Philips is recalling the HeartStart MRx Defibrillator due to a defect in the device's Gas Discharge ...

Home February 12, 2018
Home
Technology | Magnetic Resonance Imaging (MRI)

February 12, 2018 — Physicians now have access to more neuro and cardiac magnetic resonance imaging (MRI) capabilities ...

Home February 12, 2018
Home
News | Cardiovascular Ultrasound

Fox Business News recently featured GE Healthcare’s ultrasound technologies in a 6-minute segment with the Innovations ...

Home February 09, 2018
Home
Technology | Radiation Dose Management

The Instadose + dosimeter, the latest by Mirion Technologies, transforms radiation monitoring programs to increase ...

Home February 08, 2018
Home
News | Remote Viewing Systems

February 8, 2018 – Calgary Scientific announced a renewed focus on an enterprise cloud strategy, which will support its ...

Home February 08, 2018
Home
Subscribe Now